Effusive-constrictive pericarditis: current perspectives

References

• Maisch B, Seferovic PM, Ristic AD, et al; Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases. Executive summary; the Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2004;25(7):587–610.
   PubMed Web of Science ®Google Scholar
• Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases. Eur Heart J. 2015;36(42):2921–2961.
   PubMed Web of Science ®Google Scholar
• Maisch B. ESC-Webinar 2017: diagnosis and management of cardiac tamponade and constrictive pericarditis according to the ESC guidelines on pericardial disease. Available from: https://www.escardio.org/Education/E-Learning/Webinars/General-cardiology/diagnosis-and-management-of-constrictive-pericarditis.
   Google Scholar
• Goldstein JA. Cardiac tamponade, constrictive pericarditis and restrictive cardiomyopathy. Curr Probl Cardiol. 2004;29(9):503–567.
   Web of Science ®Google Scholar
• Spodick DH. The Pericardium: A Comprehensive Textbook. New York, NY: Marcel Dekker; 1997.
   Google Scholar
• Shabetai R. Pericardial Disease: Etiology, Pathophysiology, Clinical Recognition, and Treatment. New York, NY: Churchill Livingstone; 1995.
   Google Scholar
• Maisch B, Ristic AD, Seferovic P, Tsang TSM. Interventional Pericardiology. Heidelberg: Springer Medizin; 2011.
   Google Scholar
• Spodick DH, Kumar S. Subacute constrictive pericarditis with cardiac tamponade. Dis Chest. 1968;54(1):62–66.
   Google Scholar
• Hancock EW. Subacute effusive-constrictive pericarditis. Circulation. 1971;43(2):183–192.
   PubMed Web of Science ®Google Scholar
• Hancock EW. A clearer view of effusive-constrictive pericarditis. N Engl J Med. 2004;350(5):435–437.
   Web of Science ®Google Scholar
• Sagrista-Sauleda J, Angel J, Sanchez A, Permanyer-Miralda G, Soler-Soler J. Effusive-constrictive pericarditis. N Engl J Med. 2004;350(5):469–475.
   Web of Science ®Google Scholar
• Nugue O, Millaire A, Porte H, et al. Pericardioscopy in the etiologic diagnosis of pericardial effusion in 141 consecutive patients. Circulation. 1996;94(7):1635–1641.
   Web of Science ®Google Scholar
• Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Outcomes of clinically significant idiopathic pericardial effusion requiring intervention. Am J Cardiol. 2003;91(6):704–707.
   PubMed Web of Science ®Google Scholar
• Cameron J, Oesterle SN, Baldwin JC, Hancock EW. The etiologic spectrum of constrictive pericarditis. Am Heart J. 1987;113(2 Pt 1):354–360.
   PubMed Web of Science ®Google Scholar
• Maisch B, Rupp H, Ristic A, Pankuweit S. Pericardioscopy and epi- and pericardial biopsy – a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy. Heart Fail Rev. 2013;18(3):317–328.
   PubMed Web of Science ®Google Scholar
• Syed FF, Ntsekhe M, Mayosi BM, Oh JK. Effusive-constrictive pericarditis. Heart Fail Rev. 2013;18(3):277–287.
   Web of Science ®Google Scholar
• Miranda WR, Oh JK. Effusive-constrictive pericarditis. Cardiol Clin. 2017;35(4):551–558.
   Web of Science ®Google Scholar
• Maisch B, Ristic AD, Pankuweit S, Seferovic P. Percutaneous therapy in pericardial diseases. Cardiol Clin. 2017;35(4):567–588.
   PubMed Web of Science ®Google Scholar
• Van der Bijl P, Herbst P, Doubell AF. Redefining effusive-constrictive pericarditis with echocardiography. J Cardiovasc Utrasound. 2016;24(4):317–323.
   Google Scholar
• Hufnagel G, Pankuweit S, Richter A, Schönian U, Maisch B. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz. 2000;25(3):279–285.
   Web of Science ®Google Scholar
• Pankuweit S, Stein A, Karatolios K, Richter A, Ruppert V, Maisch B. Viral genomes in the pericardial fluid and in peri- and epicardial biopsies from a German cohort of patients with large to moderate pericardial effusions. Heart Fail Rev. 2013;18(3):329–336.
   Web of Science ®Google Scholar
• Ntsekhe M, Mayosi BM. Tuberculous pericarditis with and without HIV. Heart Fail Rev. 2013;18(3):367–373.
   PubMed Web of Science ®Google Scholar
• Maisch B, Ristic AD, Pankuweit S, Neubauer A, Moll R. Neoplastic pericardial effusion: efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J. 2002;23(20):1625–1631.
   Web of Science ®Google Scholar
• Maisch B, Ristic A, Pankuweit S. Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis. 2010;53(2):157–163.
   PubMed Web of Science ®Google Scholar
• Maisch B, Ristic AD, Pankuweit S. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone: the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J. 2002;23:1503–1508.
   PubMed Web of Science ®Google Scholar
• Cho YH, Schaff HV. Surgery for pericardial disease. Heart Fail Rev. 2013;18(3):375–387.
   Web of Science ®Google Scholar
• Bicer M, Oezdemir B, Kan I, Yüksel A, Tok M, Şenkaya I. Long-term outcomes of pericardiectomy for constrictive pericarditis. J Cardiothorac Surg. 2015;10:177–182.
   Web of Science ®Google Scholar
• Bush CA, Stang JM, Wooley CF, Kilman JW. Occult constrictive pericardial disease. Diagnosis by rapid volume expansion and correction by pericardiectomy. Circulation. 1977;56(6):924–930.
   Web of Science ®Google Scholar